Global Nanotechnology Drug Delivery 麻豆原创 Research Report 2024

Publication ID:

PB501242354

Publication Date:

January 24, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e. nano-technology), resulting in a number of products, including therapeutics and imaging agents, enabling more effective and less toxic therapeutic and diagnostic interventions.
The global Nanotechnology Drug Delivery market was valued at US$ 1196.4 million in 2023 and is anticipated to reach US$ 1847.5 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
Nanotechnology drug delivery is a growing field and is witnessing increasing acceptance in health care applications. Nanotechnology drug delivery is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. One important and active application area of nanotechnology drug delivery systems is to transport drugs to the final location of therapeutic intervention within the body.
This report aims to provide a comprehensive presentation of the global market for Nanotechnology Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanotechnology Drug Delivery.
Report Scope
The Nanotechnology Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanotechnology Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanotechnology Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
AbbVie
Amgen
Celgene
Johnson & Johnson
Merck & Co.
Novartis International
Perrigo Company
Pfizer
Teva Pharmaceutical Industries
Segment by Type
Nanocrystals
Nanoparticles
Liposomes
Micelles
Nanotubes
Others
Segment by Application
Neurology
Oncology
Cardiovascular/Physiology
Anti-inflammatory/Immunology
Anti-infective
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanotechnology Drug Delivery companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Nanotechnology Drug Delivery 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nanocrystals
1.2.3 Nanoparticles
1.2.4 Liposomes
1.2.5 Micelles
1.2.6 Nanotubes
1.2.7 Others
1.3 麻豆原创 by Application
1.3.1 Global Nanotechnology Drug Delivery 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Neurology
1.3.3 Oncology
1.3.4 Cardiovascular/Physiology
1.3.5 Anti-inflammatory/Immunology
1.3.6 Anti-infective
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanotechnology Drug Delivery 麻豆原创 Perspective (2019-2030)
2.2 Nanotechnology Drug Delivery Growth Trends by Region
2.2.1 Global Nanotechnology Drug Delivery 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nanotechnology Drug Delivery Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Nanotechnology Drug Delivery Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Nanotechnology Drug Delivery 麻豆原创 Dynamics
2.3.1 Nanotechnology Drug Delivery Industry Trends
2.3.2 Nanotechnology Drug Delivery 麻豆原创 Drivers
2.3.3 Nanotechnology Drug Delivery 麻豆原创 Challenges
2.3.4 Nanotechnology Drug Delivery 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanotechnology Drug Delivery Players by Revenue
3.1.1 Global Top Nanotechnology Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Nanotechnology Drug Delivery Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Nanotechnology Drug Delivery 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanotechnology Drug Delivery Revenue
3.4 Global Nanotechnology Drug Delivery 麻豆原创 Concentration Ratio
3.4.1 Global Nanotechnology Drug Delivery 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanotechnology Drug Delivery Revenue in 2023
3.5 Nanotechnology Drug Delivery Key Players Head office and Area Served
3.6 Key Players Nanotechnology Drug Delivery Product Solution and Service
3.7 Date of Enter into Nanotechnology Drug Delivery 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanotechnology Drug Delivery Breakdown Data by Type
4.1 Global Nanotechnology Drug Delivery Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Nanotechnology Drug Delivery Forecasted 麻豆原创 Size by Type (2025-2030)
5 Nanotechnology Drug Delivery Breakdown Data by Application
5.1 Global Nanotechnology Drug Delivery Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Nanotechnology Drug Delivery Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Nanotechnology Drug Delivery 麻豆原创 Size (2019-2030)
6.2 North America Nanotechnology Drug Delivery 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nanotechnology Drug Delivery 麻豆原创 Size by Country (2019-2024)
6.4 North America Nanotechnology Drug Delivery 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanotechnology Drug Delivery 麻豆原创 Size (2019-2030)
7.2 Europe Nanotechnology Drug Delivery 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nanotechnology Drug Delivery 麻豆原创 Size by Country (2019-2024)
7.4 Europe Nanotechnology Drug Delivery 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanotechnology Drug Delivery 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Nanotechnology Drug Delivery 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nanotechnology Drug Delivery 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Nanotechnology Drug Delivery 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanotechnology Drug Delivery 麻豆原创 Size (2019-2030)
9.2 Latin America Nanotechnology Drug Delivery 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nanotechnology Drug Delivery 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Nanotechnology Drug Delivery 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanotechnology Drug Delivery 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Nanotechnology Drug Delivery 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nanotechnology Drug Delivery 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Nanotechnology Drug Delivery 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Nanotechnology Drug Delivery Introduction
11.1.4 AbbVie Revenue in Nanotechnology Drug Delivery Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Nanotechnology Drug Delivery Introduction
11.2.4 Amgen Revenue in Nanotechnology Drug Delivery Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 Celgene
11.3.1 Celgene Company Detail
11.3.2 Celgene Business Overview
11.3.3 Celgene Nanotechnology Drug Delivery Introduction
11.3.4 Celgene Revenue in Nanotechnology Drug Delivery Business (2019-2024)
11.3.5 Celgene Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Nanotechnology Drug Delivery Introduction
11.4.4 Johnson & Johnson Revenue in Nanotechnology Drug Delivery Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Detail
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Nanotechnology Drug Delivery Introduction
11.5.4 Merck & Co. Revenue in Nanotechnology Drug Delivery Business (2019-2024)
11.5.5 Merck & Co. Recent Development
11.6 Novartis International
11.6.1 Novartis International Company Detail
11.6.2 Novartis International Business Overview
11.6.3 Novartis International Nanotechnology Drug Delivery Introduction
11.6.4 Novartis International Revenue in Nanotechnology Drug Delivery Business (2019-2024)
11.6.5 Novartis International Recent Development
11.7 Perrigo Company
11.7.1 Perrigo Company Company Detail
11.7.2 Perrigo Company Business Overview
11.7.3 Perrigo Company Nanotechnology Drug Delivery Introduction
11.7.4 Perrigo Company Revenue in Nanotechnology Drug Delivery Business (2019-2024)
11.7.5 Perrigo Company Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Nanotechnology Drug Delivery Introduction
11.8.4 Pfizer Revenue in Nanotechnology Drug Delivery Business (2019-2024)
11.8.5 Pfizer Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Detail
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Nanotechnology Drug Delivery Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Nanotechnology Drug Delivery Business (2019-2024)
11.9.5 Teva Pharmaceutical Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

AbbVie
Amgen
Celgene
Johnson & Johnson
Merck & Co.
Novartis International
Perrigo Company
Pfizer
Teva Pharmaceutical Industries

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.